Literature DB >> 32359844

Hyperreflective Foci in the Retina of Active Relapse-Onset Multiple Sclerosis.

Elisabetta Pilotto1, Silvia Miante2, Tommaso Torresin1, Marco Puthenparampil3, Luisa Frizziero4, Lisa Federle2, Paolo Gallo2, Edoardo Midena1.   

Abstract

Entities:  

Year:  2020        PMID： 32359844     DOI： 10.1016/j.ophtha.2020.03.024

Source DB:  PubMed          Journal:  Ophthalmology        ISSN： 0161-6420            Impact factor:   12.079


× No keyword cloud information.
  11 in total

Review 1.  Glial-mediated neuroinflammatory mechanisms in age-related macular degeneration.

Authors:  Rahul M Dhodapkar; Diego Martell; Brian P Hafler
Journal:  Semin Immunopathol       Date:  2022-05-05       Impact factor: 11.759

2.  Hyper-Reflecting Foci in Multiple Sclerosis Retina Associate With Macrophage/Microglia-Derived Cytokines in Cerebrospinal Fluid.

Authors:  Marco Puthenparampil; Tommaso Torresin; Silvia Franciotta; Annachiara Marin; Federica De Napoli; Valentina Annamaria Mauceri; Silvia Miante; Elisabetta Pilotto; Edoardo Midena; Paolo Gallo
Journal:  Front Immunol       Date:  2022-05-19       Impact factor: 8.786

3.  Retinal Hyperreflecting Foci Associate With Cortical Pathology in Multiple Sclerosis.

Authors:  Marta Pengo; Silvia Miante; Silvia Franciotta; Marta Ponzano; Tommaso Torresin; Francesca Bovis; Francesca Rinaldi; Paola Perini; Martina Saiani; Monica Margoni; Alessandra Bertoldo; Maria Pia Sormani; Elisabetta Pilotto; Edoardo Midena; Paolo Gallo; Marco Puthenparampil
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2022-05-23

4.  OCT Hyperreflective Retinal Foci in Diabetic Retinopathy: A Semi-Automatic Detection Comparative Study.

Authors:  Edoardo Midena; Tommaso Torresin; Erika Velotta; Elisabetta Pilotto; Raffaele Parrozzani; Luisa Frizziero
Journal:  Front Immunol       Date:  2021-04-22       Impact factor: 7.561

5.  Retinal Glial Cells in Von Hippel-Lindau Disease: A Novel Approach in the Pathophysiology of Retinal Hemangioblastoma.

Authors:  Elisabetta Pilotto; Giulia Midena; Tommaso Torresin; Gilda De Mojà; Maria Laura Bacelle; Alfonso Massimiliano Ferrara; Stefania Zovato; Edoardo Midena
Journal:  Cancers (Basel)       Date:  2021-12-30       Impact factor: 6.639

Review 6.  Optical coherence tomography as retinal imaging biomarker of neuroinflammation/neurodegeneration in systemic disorders in adults and children.

Authors:  Stela Vujosevic; M Margarita Parra; M Elizabeth Hartnett; Louise O'Toole; Alessia Nuzzi; Celeste Limoli; Edoardo Villani; Paolo Nucci
Journal:  Eye (Lond)       Date:  2022-04-15       Impact factor: 4.456

7.  Hyper-reflective retinal foci as possible in vivo imaging biomarker of microglia activation in von Hippel-Lindau disease.

Authors:  Elisabetta Pilotto; Tommaso Torresin; Maria Laura Bacelle; Gilda De Mojà; Alfonso Massimiliano Ferrara; Stefania Zovato; Giulia Midena; Edoardo Midena
Journal:  PLoS One       Date:  2022-08-12       Impact factor: 3.752

Review 8.  Neuroinflammation and neurodegeneration in diabetic retinopathy.

Authors:  Lorenzo Bianco; Alessandro Arrigo; Emanuela Aragona; Alessio Antropoli; Alessandro Berni; Andrea Saladino; Maurizio Battaglia Parodi; Francesco Bandello
Journal:  Front Aging Neurosci       Date:  2022-08-16       Impact factor: 5.702

9.  Retinal inner nuclear layer thinning is decreased and associates with the clinical outcome in ocrelizumab-treated primary progressive multiple sclerosis.

Authors:  Alessandro Miscioscia; Marco Puthenparampil; Silvia Miante; Marta Pengo; Francesca Rinaldi; Paola Perini; Paolo Gallo
Journal:  J Neurol       Date:  2022-06-01       Impact factor: 6.682

10.  Imaging Hyperreflective Foci as an Inflammatory Biomarker after Anti-VEGF Treatment in Neovascular Age-Related Macular Degeneration Patients with Optical Coherence Tomography Angiography.

Authors:  Jing Wu; Chaoyang Zhang; Qian Yang; Hai Xie; Jingting Zhang; Qinghua Qiu; Kun Liu; Dawei Luo; Fang Liu; Jingfa Zhang
Journal:  Biomed Res Int       Date:  2021-02-03       Impact factor: 3.411
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.